Ponatinib Showcases Long-Term Efficacy, Safety in CP-CML With T315I Mutations
Ponatinib generated long-term efficacy and displayed manageable safety in chronic-phase chronic myeloid leukemia harboring a T315I mutation.
Source: onclive.com
📰 Michael Deininger News
Michael Deininger News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Deininger. Real-time updates on events, politics, business and more.
A Look Into Selecting TKIs for CML Treatment
Given the wealth of available options, the selection of tyrosine kinase inhibitors for patients with chronic myeloid leukemia is faced with a plethora of nuanced decisions.
United States Michael Deininger College Of Wisconsin Meeting Of The Society Hematologic Oncology Versiti Blood Research Institute Annual Meeting
Source: onclive.com
TKI Selection in CML Demands Nuanced Approaches
Choosing the most effective TKIs for individual patients with chronic myeloid leukemia requires decision making based on efficacy data, agent safety profiles, and patient characteristics, according to Michael Deininger, MD.
United States Michael Deininger Society Of Hematologic Oncology Meeting Of The Society Hematologic Oncology Versiti Blood Research Institute Bristol Myers Squibb
Source: onclive.com
Expansion Plans for Versiti Blood Research Institute Win Key Support from Wisconsin's Joint Committee on Finance
MILWAUKEE, June 7, 2023 /PRNewswire/ -- Versiti Wisconsin expresses its sincere gratitude to the members of the Joint Finance Committee for approving a $10 million grant to expand Versitis Blood
United States Chris Miskel Michael Deininger National Institutes Of Health Milwaukee Regional Medical Center Department Of Defense
Source: wsiltv.com
Expansion Plans for Versiti Blood Research Institute Win Key Support from Wisconsin's Joint Committee on Finance » Urban Milwaukee
United States Michael Deininger Chris Miskel Milwaukee Regional Medical Center Department Of Defense National Institutes Of Health
Source: urbanmilwaukee.com
Expansion Plans for Versiti Blood Research Institute Win Key Support from Wisconsin's Joint Committee on Finance
/PRNewswire/ -- Versiti Wisconsin expresses its sincere gratitude to the members of the Joint Finance Committee for approving a $10 million grant to expand...
United States Chris Miskel Michael Deininger Milwaukee Regional Medical Center Department Of Defense Versiti Blood Research Institute
Source: prnewswire.com
Versiti Blood Research Institute: Applauds Wisconsin's commitment to advancing blood health research
MILWAUKEE – Feb. 28, 2023 – Today, the State of Wisconsin proposed a life-saving investment of $10 million to expand the Versiti Blood Research In
Source: wispolitics.com
Versiti plans new building to accommodate more than 100 new jobs on Milwaukee Regional Medical Center campus
Versiti Inc. plans to develop a new blood research building on the Milwaukee Regional Medical Center campus that could house more than 100 new employees.
United States Medical College Of Wisconsin Chris Miskel Michael Deininger Versiti Inc Blood Research Institute
Source: biztimes.com
ODU Team Leads Study into Potential Role of Gas Plasma in
Norfolk, VA, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Old Dominion University researchers have discovered a potential major treatment approach to overcome...
Source: globenewswire.com
Journal Nature Medicine Features Co-development of "Game-changing" Drug by Versiti Chief Scientific Officer Dr. Michael Deininger
Press release content from PR Newswire. The AP news staff was not involved in its creation.
United States Michael Deininger Transdisciplinary Research Cancer Center Drug Administration College Of Wisconsin
Source: apnews.com